Sreeven Pharma Private Limited

Sreeven Pharma Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials and compliance.
CIN U65993TG1992PTC014481 Incorporated 08 July 1992 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹1.92 Cr
▲ 284.00% YoY
EBITDA · FY 2025
*****
▼ 76.00% YoY
Net profit · FY 2025
*****
▼ 74.00% YoY
Authorised capital
₹5 Cr
Registered with MCA
Paid-up capital
₹3.69 Cr
Issued & subscribed
Open charges
₹6 Cr
Satisfied ₹9.06 Cr
Company age
34 yrs
Est. 1992
Last financials
Mar 2025
Balance sheet date

About Sreeven Pharma Private Limited

Data last updated: 21 December 2025

Sreeven Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 08 July 1992, the company has been in operation for over 34 years.

Registered with ROC Hyderabad under CIN U65993AP1992PTC014481.

Capital: an authorised share capital of ₹5 Cr and a paid-up capital of ₹3.69 Cr. Formerly known as Richie Investments & Consultants Pvt Ltd. It is led by directors Sandeep Gokaraju and Devendrappa Jegashetty.

Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: H.No. 11 – 15 – 25 Doctors Colony Lb Nagar, Hyderabad, Telangana, India – 500074.

As per the financials filed for FY 2025, the company reported a revenue of ₹1.92 Cr, reflecting significant growth compared to the previous year.

As per MCA filings, the company has open charges of ₹6 Cr and satisfied charges of ₹9.06 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies.

Company Details of Sreeven Pharma Private Limited
CIN U65993TG1992PTC014481
Registration Number 014481
Incorporation Date 08 July 1992
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Key People
Devendrappa Jegashetty Managing Director Sandeep Gokaraju Director
Contact Details
  • Email
    **************
  • Telephone
    **************
  • Website
    **************
  • Social Media
    **************
  • Registered Address
    H.No. 11 – 15 – 25 Doctors Colony Lb Nagar, Hyderabad, Telangana, India – 500074
  • Industry
    Pharma, Drug Formulation & Development
Company report
Sreeven Pharma Private Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Sreeven Pharma Private Limited report

Financials, compliance, directors, charges, ownership and filings for Sreeven Pharma Private Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Sreeven Pharma Private Limited

Sreeven Pharma Private Limited has one previous CIN (Corporate Identification Number): U65993AP1992PTC014481. The current CIN is U65993TG1992PTC014481, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
U65993TG1992PTC014481 Current
U65993AP1992PTC014481 Previous

Business Activity of Sreeven Pharma Private Limited

Sreeven Pharma Private Limited is engaged in the principal business activity of trade, with detailed activities including retail trading.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
G Trade G2 Retail Trading *********

Board of Directors of Sreeven Pharma Private Limited

Sreeven Pharma Private Limited is currently managed by 2 directors, with 6 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Sandeep Gokaraju
Also directs: Tyche Industries Limited, Sirona Life Sciences Private Limited
Director 15 Jul 2022 3 Years 11 Months Current
Devendrappa Jegashetty
Also directs: Divyasree Laboratories India Private Limited, Bidar Pharma Testing Research And Development Foundation
Managing Director 11 Apr 2003 23 Years 2 Months Current
View all directors

Financials of Sreeven Pharma Private Limited FY 2025 filings available

Sreeven Pharma Private Limited reported revenue of ₹1.92 Cr (up 284% YoY) for FY 2025. Profit growth despite declining revenue indicates effective cost management and margin discipline.

Revenue
₹1.92 Cr ▲ 284%
Profit
***** ▼ -74%
EBITDA
***** ▼ -76%
Metrics
*****
*****
*****
*****
*****
Revenue
Revenue from Operations
*****
*****
*****
*****
*****
Revenue Growth %
*****
*****
*****
*****
*****
Other Income
*****
*****
*****
*****
*****
Total Revenue
*****
*****
*****
*****
*****
Expenses
Total Expenses
*****
*****
*****
*****
*****
Raw Material Cost
*****
*****
*****
*****
*****
Change in Inventory FG
*****
*****
*****
*****
*****
Change in Inventory WIP
*****
*****
*****
*****
*****
Purchase of Traded Goods
*****
*****
*****
*****
*****
Employee Cost
*****
*****
*****
*****
*****
Managerial Remuneration
*****
*****
*****
*****
*****
Audit Fees
*****
*****
*****
*****
*****
Insurance
*****
*****
*****
*****
*****
Power & Fuel
*****
*****
*****
*****
*****
Interest
*****
*****
*****
*****
*****
Depreciation
*****
*****
*****
*****
*****
Other Expenses
*****
*****
*****
*****
*****
Profitability
EBITDA (Operating Profit)
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
Exceptional Items
*****
*****
*****
*****
*****
Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Exceptional & Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Tax
*****
*****
*****
*****
*****
Tax & Net Profit
Tax Expense
*****
*****
*****
*****
*****
Current Tax
*****
*****
*****
*****
*****
Deferred Tax
*****
*****
*****
*****
*****
Profit from Discontinued Operations
*****
*****
*****
*****
*****
Tax on Discontinued Operations
*****
*****
*****
*****
*****
Profit
*****
*****
*****
*****
*****
Net Margin %
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Shareholders' Funds
Total Shareholders' Funds
*****
*****
*****
*****
*****
Equity Capital
*****
*****
*****
*****
*****
Reserves & Surplus
*****
*****
*****
*****
*****
Money Against Warrants
*****
*****
*****
*****
*****
Other Equity
*****
*****
*****
*****
*****
Non-Current Liabilities
Total Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Borrowings
*****
*****
*****
*****
*****
Deferred Tax Liabilities
*****
*****
*****
*****
*****
Other Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Provisions
*****
*****
*****
*****
*****
Current Liabilities
Total Current Liabilities
*****
*****
*****
*****
*****
Short-Term Borrowings
*****
*****
*****
*****
*****
Trade Payables
*****
*****
*****
*****
*****
Other Current Liabilities
*****
*****
*****
*****
*****
Short-Term Provisions
*****
*****
*****
*****
*****
Total Equity & Liabilities
*****
*****
*****
*****
*****
Non-Current Assets
Non-Current Assets
*****
*****
*****
*****
*****
Tangible Assets
*****
*****
*****
*****
*****
Intangible Assets
*****
*****
*****
*****
*****
Capital WIP
*****
*****
*****
*****
*****
Intangibles Under Dev
*****
*****
*****
*****
*****
Investments
*****
*****
*****
*****
*****
Deferred Tax Assets
*****
*****
*****
*****
*****
LT Loans & Advances
*****
*****
*****
*****
*****
Other Non-Current Assets
*****
*****
*****
*****
*****
Current Assets
Current Assets
*****
*****
*****
*****
*****
Current Investments
*****
*****
*****
*****
*****
Inventories
*****
*****
*****
*****
*****
Trade Receivables
*****
*****
*****
*****
*****
Cash & Bank Balance
*****
*****
*****
*****
*****
ST Loans & Advances
*****
*****
*****
*****
*****
Other Current Assets
*****
*****
*****
*****
*****
Total Assets
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Cash from Operating Activities (CFO)
Profit Before Tax
*****
*****
*****
*****
*****
Non-Cash Adjustments
*****
*****
*****
*****
*****
+ Interest Expense
*****
*****
*****
*****
*****
+ Depreciation
*****
*****
*****
*****
*****
+/- Unrealized Forex
*****
*****
*****
*****
*****
- Dividend Income
*****
*****
*****
*****
*****
- Interest Income
*****
*****
*****
*****
*****
+/- Other Non-Cash Items
*****
*****
*****
*****
*****
Changes in Working Capital
*****
*****
*****
*****
*****
+/- Inventory
*****
*****
*****
*****
*****
+/- Debtors
*****
*****
*****
*****
*****
+/- Creditors
*****
*****
*****
*****
*****
Reconciliation Adjustments
*****
*****
*****
*****
*****
Cash Generated from Operations
*****
*****
*****
*****
*****
Income Taxes Paid
*****
*****
*****
*****
*****
Net CFO (Cash from Operations)
*****
*****
*****
*****
*****
Cash from Investing Activities (CFI)
Acquisitions & Disposals
*****
*****
*****
*****
*****
Disposal of Subsidiaries
*****
*****
*****
*****
*****
Acquisition of Subsidiaries
*****
*****
*****
*****
*****
Capex
*****
*****
*****
*****
*****
Purchase of Fixed Assets
*****
*****
*****
*****
*****
Sale of Fixed Assets
*****
*****
*****
*****
*****
Other Investing Cash Flows
*****
*****
*****
*****
*****
Net CFI (Cash from Investing)
*****
*****
*****
*****
*****
Cash from Financing Activities (CFF)
Equity Issuance
*****
*****
*****
*****
*****
Debt Raised
*****
*****
*****
*****
*****
Debt Repaid
*****
*****
*****
*****
*****
Dividends Paid
*****
*****
*****
*****
*****
Interest Paid
*****
*****
*****
*****
*****
Net CFF (Cash from Financing)
*****
*****
*****
*****
*****
Net Cash Position
Net Change in Cash (Pre-Forex)
*****
*****
*****
*****
*****
Closing Cash & Equivalents
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Liquidity
Current Ratio
*****
*****
*****
*****
*****
Quick Ratio
*****
*****
*****
*****
*****
Cash Ratio
*****
*****
*****
*****
*****
Efficiency
Inventory Days
*****
*****
*****
*****
*****
Debtor Days
*****
*****
*****
*****
*****
Creditor Days
*****
*****
*****
*****
*****
Cash Conversion Cycle
*****
*****
*****
*****
*****
Asset Turnover
*****
*****
*****
*****
*****
Profitability
Net Profit Margin %
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
ROE %
*****
*****
*****
*****
*****
ROCE %
*****
*****
*****
*****
*****
Net Worth Margin %
*****
*****
*****
*****
*****
Growth
Revenue Growth %
*****
*****
*****
*****
*****
Leverage
Equity Multiplier
*****
*****
*****
*****
*****
Debt / EBITDA
*****
*****
*****
*****
*****
Solvency
D/E Ratio
*****
*****
*****
*****
*****
ICR
*****
*****
*****
*****
*****

Consolidated Statements

Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.

Unlock Complete Financial History (FY 2015 – Latest)
Standalone & Consolidated - Income Statement, Balance Sheet, Cash Flow, Financial Ratios and Growth Trends with 10+ years of line-item data.
10+ years of data Line-item breakdown Balance Sheet detail Cash Flow analysis 20+ ratios & metrics Downloadable PDF

Charges & Borrowings of Sreeven Pharma Private Limited

Open charges
₹6 Cr
Satisfied charges
₹9.06 Cr
Breakdown by lending institutions
Axis Bank Limited₹6.00 Cr
Latest charge details
DateLenderAmountStatus
19 Aug 2024 Axis Bank Limited ₹6 Cr Open
27 Jan 2017 Syndicate Bank ₹1.2 Cr Satisfied
22 Feb 2016 Canara Bank ₹4.95 Cr Satisfied
26 Aug 2011 Axis Bank Limited ₹2.21 Cr Satisfied
31 Oct 2008 Syndicate Bank ₹70 Lakh Satisfied

Total charge records: 5 View all charges

Employees and EPFO Compliance at Sreeven Pharma Private Limited

View historical data on people associated with Sreeven Pharma Private Limited, including employment history and EPFO contributions.

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026

Employee Count & EPFO Data of Sreeven Pharma Private Limited

Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.

Monthly employee headcount & PF contributions
EPFO establishment details & ECR filing status
Year-wise workforce analytics & attrition trends
PF exemption, coverage & compliance verification

GST Compliance of Sreeven Pharma Private Limited

XX%
Compliant
GSTR-1
GSTR-3B
GSTR-9
MH
KA
UP
TN
TS

GSTIN & GST Filing Data of Sreeven Pharma Private Limited

Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.

GSTIN registrations & state-wise presence
Filing compliance - GSTR-1, GSTR-3B, GSTR-9
HSN/SAC codes with goods & services details
Taxpayer type, jurisdiction & business constitution

Credit Ratings, Litigation & Regulatory Alerts for Sreeven Pharma Private Limited

Credit rating
AAA
AA+
AA
AA-
! !
2015 2017 2019 2021 2023
Litigation
District Court 35
High Court 45
Supreme Court 0
NCLT / NCLAT 0
Pending
Disposed
Regulatory alerts
GSTIN Cancelled
Andhra Pradesh
GSTIN Cancelled
Telangana (on application)
EPFO Delay
12 months delay - Haryana
Violations via Directors
20 MCA + 19 Bank defaults

Credit Ratings, Legal Cases & Regulatory Alerts of Sreeven Pharma Private Limited

Access complete credit rating history, litigation records, regulatory alerts, and compliance data.

Credit rating history across CARE, ICRA, Brickwork & India Ratings
Instrument-wise ratings, outlook & action timeline
Court-wise litigation (District, High Court, Supreme Court, NCLT)
Group company & common directorship litigation
Statutory compliance alerts (GSTIN, EPFO, ROC)
Director & company violations (MCA, SEBI, Banks, BSE/NSE)

MSME Payment Delays by Sreeven Pharma Private Limited

MSME Payment Delays by Sreeven Pharma Private Limited

Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.

Amounts outstanding to MSME suppliers
Delay periods & reasons for delayed payments
Half-yearly MSME-1 filing history
Vendor-payment behaviour as a counterparty risk signal

Subsidiaries & Group Companies of Sreeven Pharma Private Limited

Subsidiaries & Group Companies of Sreeven Pharma Private Limited

See the full corporate group - holding company, subsidiaries, associates and joint ventures of Sreeven Pharma Private Limited with ownership details.

Holding & parent company details
Subsidiaries & step-down subsidiaries with % holding
Associates & joint ventures with partner details
Investments in other entities year-on-year

MCA Filings & Documents of Sreeven Pharma Private Limited

MCA Filings & Documents of Sreeven Pharma Private Limited

Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.

Incorporation documents, MoA & AoA
Annual returns (MGT-7) & financial statements (AOC-4)
Charge filings (CHG-1, CHG-4) & resolutions
Complete document index with filing dates

Recent Activity on Sreeven Pharma Private Limited

Activity
30 Sep 2025
Sreeven Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Activity
31 Mar 2025
Sreeven Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Charges
19 Aug 2024
A charge with Axis Bank Limited amounted to Rs. 6.00 Cr with Charge ID 100972431 was registered on 19 Aug 2024.
Charges
10 Oct 2022
A charge registered on 27 Jan 2017 via Charge ID 100083574 with Syndicate Bank was fully satisfied on 10 Oct 2022.
Charges
10 Oct 2022
A charge registered on 22 Feb 2016 via Charge ID 10627736 with Canara Bank was fully satisfied on 10 Oct 2022.
Directors
15 Jul 2022
Sandeep Gokaraju was appointed as a Director on 15 Jul 2022 & has been associated with this company since 3 years 11 months.

Frequently Asked Questions about Sreeven Pharma Private Limited

Sreeven Pharma Private Limited is an active private limited company in the pharma sector based in Hyderabad, Telangana, India. It was incorporated on 08 July 1992 (34+ years old) and is registered under CIN U65993TG1992PTC014481.

Sreeven Pharma Private Limited reported revenue of ₹1.92 Cr for FY 2025 (up 284.00% YoY).

The current directors of Sreeven Pharma Private Limited are:

The primary industry of Sreeven Pharma Private Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.

Sreeven Pharma Private Limited can be reached at the registered office: H.No. 11 – 15 – 25 Doctors Colony Lb Nagar, Hyderabad, Telangana, India – 500074.

The authorised capital is ₹5 Cr, and the paid-up capital is ₹3.69 Cr.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available